Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?

L. J. Gates, N. Benjamin, Neva Elizabeth Haites, A. A. MacConnachie, James Stuart McLay

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Introduction: Glucocorticoid-remediable aldosteronism (GRA) is a rare inherited cause for hypertension associated with a significant morbidity and mortality at an early age. Individuals with this abnormality frequently present with severe hypertension which is resistant to standard antihypertensive therapy, a strong family history of hypertension, intracranial haemorrhage, and sporadic hypokalaemia. However many affected individuals may appear phenotypically indistinguishable from normal essential hypertensives but remain at high risk of morbidity and mortality.

objective: To determine how effective random or targeted screening of hypertensive patients is for the detection of GRA.

Design: A prospective study involving the screening of 300 hypertensive patients chosen at random attending the Aberdeen Hypertension Clinic and, during the same period, the targeted screening of patients with a medicaland family history suggestive of GRA.

Setting: A University hospital with a primary catchment of 500000 inhabitants and a hypertension clinic population of over 8500 patients.

Results: Random screening failed to identify any GRA mutation-positive individuals. Targeted screening of selected individuals revealed two index families and four further families containing 40 mutation-positive individuals.

Conclusion: Targeted screening of hypertensive individuals with a family history of hypertension, cerebral haemorrhage, a history of hypertension from an early age, resistant hypertension which has proven difficult to control and hypokalaemia revealed two index cases and four further individuals and 30 hypertensive and 10 normotensive members of their families with GRA.

Original languageEnglish
Pages (from-to)173-176
Number of pages3
JournalJournal of Human Hypertension
Volume15
Issue number3
DOIs
Publication statusPublished - 2001

Keywords

  • hypokalaemia
  • screening
  • cerebral haemorrhage
  • glucocorticoid remedial alodosteronism

Cite this

Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population? / Gates, L. J.; Benjamin, N.; Haites, Neva Elizabeth; MacConnachie, A. A.; McLay, James Stuart.

In: Journal of Human Hypertension, Vol. 15, No. 3, 2001, p. 173-176.

Research output: Contribution to journalArticle

Gates, L. J. ; Benjamin, N. ; Haites, Neva Elizabeth ; MacConnachie, A. A. ; McLay, James Stuart. / Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?. In: Journal of Human Hypertension. 2001 ; Vol. 15, No. 3. pp. 173-176.
@article{10edf0053abb4ca4bde3b621e53aebc0,
title = "Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?",
abstract = "Introduction: Glucocorticoid-remediable aldosteronism (GRA) is a rare inherited cause for hypertension associated with a significant morbidity and mortality at an early age. Individuals with this abnormality frequently present with severe hypertension which is resistant to standard antihypertensive therapy, a strong family history of hypertension, intracranial haemorrhage, and sporadic hypokalaemia. However many affected individuals may appear phenotypically indistinguishable from normal essential hypertensives but remain at high risk of morbidity and mortality.objective: To determine how effective random or targeted screening of hypertensive patients is for the detection of GRA.Design: A prospective study involving the screening of 300 hypertensive patients chosen at random attending the Aberdeen Hypertension Clinic and, during the same period, the targeted screening of patients with a medicaland family history suggestive of GRA.Setting: A University hospital with a primary catchment of 500000 inhabitants and a hypertension clinic population of over 8500 patients.Results: Random screening failed to identify any GRA mutation-positive individuals. Targeted screening of selected individuals revealed two index families and four further families containing 40 mutation-positive individuals.Conclusion: Targeted screening of hypertensive individuals with a family history of hypertension, cerebral haemorrhage, a history of hypertension from an early age, resistant hypertension which has proven difficult to control and hypokalaemia revealed two index cases and four further individuals and 30 hypertensive and 10 normotensive members of their families with GRA.",
keywords = "hypokalaemia, screening, cerebral haemorrhage, glucocorticoid remedial alodosteronism",
author = "Gates, {L. J.} and N. Benjamin and Haites, {Neva Elizabeth} and MacConnachie, {A. A.} and McLay, {James Stuart}",
year = "2001",
doi = "10.1038/sj.jhh.1001152",
language = "English",
volume = "15",
pages = "173--176",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?

AU - Gates, L. J.

AU - Benjamin, N.

AU - Haites, Neva Elizabeth

AU - MacConnachie, A. A.

AU - McLay, James Stuart

PY - 2001

Y1 - 2001

N2 - Introduction: Glucocorticoid-remediable aldosteronism (GRA) is a rare inherited cause for hypertension associated with a significant morbidity and mortality at an early age. Individuals with this abnormality frequently present with severe hypertension which is resistant to standard antihypertensive therapy, a strong family history of hypertension, intracranial haemorrhage, and sporadic hypokalaemia. However many affected individuals may appear phenotypically indistinguishable from normal essential hypertensives but remain at high risk of morbidity and mortality.objective: To determine how effective random or targeted screening of hypertensive patients is for the detection of GRA.Design: A prospective study involving the screening of 300 hypertensive patients chosen at random attending the Aberdeen Hypertension Clinic and, during the same period, the targeted screening of patients with a medicaland family history suggestive of GRA.Setting: A University hospital with a primary catchment of 500000 inhabitants and a hypertension clinic population of over 8500 patients.Results: Random screening failed to identify any GRA mutation-positive individuals. Targeted screening of selected individuals revealed two index families and four further families containing 40 mutation-positive individuals.Conclusion: Targeted screening of hypertensive individuals with a family history of hypertension, cerebral haemorrhage, a history of hypertension from an early age, resistant hypertension which has proven difficult to control and hypokalaemia revealed two index cases and four further individuals and 30 hypertensive and 10 normotensive members of their families with GRA.

AB - Introduction: Glucocorticoid-remediable aldosteronism (GRA) is a rare inherited cause for hypertension associated with a significant morbidity and mortality at an early age. Individuals with this abnormality frequently present with severe hypertension which is resistant to standard antihypertensive therapy, a strong family history of hypertension, intracranial haemorrhage, and sporadic hypokalaemia. However many affected individuals may appear phenotypically indistinguishable from normal essential hypertensives but remain at high risk of morbidity and mortality.objective: To determine how effective random or targeted screening of hypertensive patients is for the detection of GRA.Design: A prospective study involving the screening of 300 hypertensive patients chosen at random attending the Aberdeen Hypertension Clinic and, during the same period, the targeted screening of patients with a medicaland family history suggestive of GRA.Setting: A University hospital with a primary catchment of 500000 inhabitants and a hypertension clinic population of over 8500 patients.Results: Random screening failed to identify any GRA mutation-positive individuals. Targeted screening of selected individuals revealed two index families and four further families containing 40 mutation-positive individuals.Conclusion: Targeted screening of hypertensive individuals with a family history of hypertension, cerebral haemorrhage, a history of hypertension from an early age, resistant hypertension which has proven difficult to control and hypokalaemia revealed two index cases and four further individuals and 30 hypertensive and 10 normotensive members of their families with GRA.

KW - hypokalaemia

KW - screening

KW - cerebral haemorrhage

KW - glucocorticoid remedial alodosteronism

U2 - 10.1038/sj.jhh.1001152

DO - 10.1038/sj.jhh.1001152

M3 - Article

VL - 15

SP - 173

EP - 176

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

SN - 0950-9240

IS - 3

ER -